Form 8-K - Current report:
SEC Accession No. 0001104659-23-078746
Filing Date
2023-07-06
Accepted
2023-07-06 16:15:45
Documents
12
Period of Report
2023-07-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320739d1_8k.htm   iXBRL 8-K 30262
  Complete submission text file 0001104659-23-078746.txt   204567

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pahc-20230705.xsd EX-101.SCH 3271
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20230705_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20230705_pre.xml EX-101.PRE 22351
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2320739d1_8k_htm.xml XML 3379
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 231073776
SIC: 2834 Pharmaceutical Preparations